Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Habermann

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Oncology Nursing Forum|November 1, 1989
Alpha interferon: progress and perspectives in the biotherapy of chronic myelogenous leukemiaT M Habermann
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 9, 2000
Monoclonal antibody therapy for posttransplant lymphoproliferative disordersT M Habermann
Hospital Practice (1995)|December 28, 1999
Non-Hodgkin's lymphoma: present status and future prospectsT M Habermann
Mayo Clinic Proceedings|July 25, 2000
LymphadenopathyT M Habermann, D P Steensma
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2018
Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galiën et alM J Maurer, T M Habermann
Mayo Clinic Proceedings|October 19, 2001
Images and reflections from Mayo Clinic heritageT M Habermann, R E Ziemer, C S Beck
Mayo Clinic Proceedings|August 14, 2001
Images and reflections from Mayo Clinic heritageT M Habermann, R E Ziemer, C S Beck
Seminars in Oncology|June 22, 1999
Primary thyroid lymphomaS M Ansell, C S Grant, T M Habermann
The American Journal of Medicine|July 1, 1989
Severe neuropathy associated with low-dose recombinant interferon-alphaD A Gastineau, T M Habermann, R C Hermann
Mayo Clinic Proceedings|June 8, 2001
Images and reflections from Mayo Clinic heritageT M Habermann, R E Ziemer, C S Beck
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Oncology Nursing Forum|November 1, 1989
Alpha interferon: progress and perspectives in the biotherapy of chronic myelogenous leukemiaT M Habermann
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 9, 2000
Monoclonal antibody therapy for posttransplant lymphoproliferative disordersT M Habermann
Hospital Practice (1995)|December 28, 1999
Non-Hodgkin's lymphoma: present status and future prospectsT M Habermann
Mayo Clinic Proceedings|July 25, 2000
LymphadenopathyT M Habermann, D P Steensma
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2018
Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galiën et alM J Maurer, T M Habermann
Mayo Clinic Proceedings|October 19, 2001
Images and reflections from Mayo Clinic heritageT M Habermann, R E Ziemer, C S Beck
Mayo Clinic Proceedings|August 14, 2001
Images and reflections from Mayo Clinic heritageT M Habermann, R E Ziemer, C S Beck
Seminars in Oncology|June 22, 1999
Primary thyroid lymphomaS M Ansell, C S Grant, T M Habermann
The American Journal of Medicine|July 1, 1989
Severe neuropathy associated with low-dose recombinant interferon-alphaD A Gastineau, T M Habermann, R C Hermann
Mayo Clinic Proceedings|June 8, 2001
Images and reflections from Mayo Clinic heritageT M Habermann, R E Ziemer, C S Beck
Pageof 10